🍽🦠 PubMed Studies Citing Bacteria Shifts for 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} - Enterobacteriaceae

Citations are updated once a week. Recently added citations may not appear.

4 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
📓 - Direct Citation   |   👪 - Infer Parent  |   👶 - Infer Child |   ⚗️ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😢 - Shifts in wrong direction
Context Citation
2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} - Enterobacteriaceae    👪 Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson`s Disease.
Frontiers in neuroscience (Front Neurosci ) Vol: 14 Issue Pages: 549037
Pub: 2020 Epub: 2020 Dec 14 Authors Chen TJ , Feng Y , Liu T , Wu TT , Chen YJ , Li X , Li Q , Wu YC ,
Html Article Publication
2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} - Enterobacteriaceae    📓 Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors.
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 926104
Pub: 2022 Epub: 2022 Jun 22 Authors Zhang Y , Chen C , Cheng B , Gao L , Qin C , Zhang L , Zhang X , Wang J , Wan Y ,
Html Article Publication
2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} - Enterobacteriaceae    👪 Fisetin inhibits Salmonella Typhimurium type III secretion system regulator HilD and reduces pathology in vivo.
Microbiology spectrum (Microbiol Spectr ) Vol: 12 Issue 1 Pages: e0240623
Pub: 2024 Jan 11 Epub: 2023 Dec 11 Authors Li S , Liu H , Shu J , Li Q , Liu Y , Feng H , Wang J , Deng X , Zhang Y , Guo Z , Qiu J ,
Html Article Publication
2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} - Enterobacteriaceae    👪 Differences in the hydroxylation pattern of flavonoids alter their chemoprotective effect against direct- and indirect-acting mutagens.
Food chemistry (Food Chem ) Vol: 155 Issue Pages: 251-5
Pub: 2014 Jul 15 Epub: 2014 Jan 30 Authors Resende FA , da Silva Almeida CP , Vilegas W , Varanda EA ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)